| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AS3MT
|
arsenite methyltransferase
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
BAX
|
BCL2-associated X protein
|
|
BAZ1A
|
bromodomain adjacent to zinc finger domain, 1A
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BGN
|
biglycan
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CARTPT
|
CART prepropeptide
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX5
|
chromobox homolog 5
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CUZD1
|
CUB and zona pellucida-like domains 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DNM1L
|
dynamin 1-like
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EMD
|
emerin
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGF23
|
fibroblast growth factor 23
|
|
FMR1
|
fragile X mental retardation 1
|
|
GBA
|
glucosidase, beta, acid
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HFE
|
hemochromatosis
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HTT
|
huntingtin
|
|
IFNA1
|
interferon, alpha 1
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
JAK3
|
Janus kinase 3
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KRT18
|
keratin 18, type I
|
|
LCN2
|
lipocalin 2
|
|
MFN1
|
mitofusin 1
|
|
MFN2
|
mitofusin 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MLANA
|
melan-A
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPZ
|
myelin protein zero
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUTYH
|
mutY homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAX8
|
paired box 8
|
|
PDYN
|
prodynorphin
|
|
PER2
|
period circadian clock 2
|
|
PRNP
|
prion protein
|
|
PROX1
|
prospero homeobox 1
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RBM10
|
RNA binding motif protein 10
|
|
RHD
|
Rh blood group, D antigen
|
|
RNF180
|
ring finger protein 180
|
|
S100P
|
S100 calcium binding protein P
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SYK
|
spleen tyrosine kinase
|
|
TBX5
|
T-box 5
|
|
TCF4
|
transcription factor 4
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
UBB
|
ubiquitin B
|
|
VCP
|
valosin containing protein
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
ZIC2
|
Zic family member 2
|
|
ZIC5
|
Zic family member 5
|
